Gold buying price jumps 0.9% to 16,433.5 drams in Armenia

YEREVAN, March 11. /ARKA/. The State Depository of Precious Stones and Metals Agency, an affiliation of Armenian Finance Ministry, has set new prices for government agencies to buy and sell precious stones and metals which are effective for this week. The gold price rose from last week 0.9% or by 146.13 drams to 16,433.5 drams.

The gold selling price is set at 17,862.53 drams (+159.05).

The prices are for one gram of chemically pure metals.

Silver is to be bought at 260.87 drams (-3.68) and sold at 283.55 drams (- 4); platinum is to be bought at 17,981.92 drams (+417.59), and sold at 19,545.56 drams (453.9); palladium is to be bought at 9,370.43 drams (+339.31), and sold at 10,185.25 drams (368.81). ($1=414.84drams). -0—

spot_img

POPULAR

Armenian dram strengthens against US dollar and weakens against euro and ruble

YEREVAN, August 21. /ARKA/. The average market exchange rate of the US dollar to the Armenian dram on the Armenian foreign exchange market on August 21, 2026, fell by 0.1 point to 365.16 drams compared to August 20.

S&P: Armenia’s banking sector is well capitalized and highly profitable

Armenia's banking sector remains well capitalized and highly profitable, supported by high net interest income and robust economic growth, according to a report from international rating agency S&P Global Ratings.

Armenian dram weakened against the dollar and strengthened against the euro and ruble: Central Bank

The average market exchange rate for the US dollar to the Armenian dram, formed on the Armenian foreign exchange market as of August 24, 2026, increased by 0.22 points to 365.38 drams compared to August 21.

Record growth of Armenia’s reserves to $6.9 billion in June provided a buffer amid heightened geopolitical risks – S&P

Armenia's international reserves increased by approximately 40% year-on-year to a record $6.9 billion in June 2026, helping to strengthen the country's external reserves despite heightened geopolitical risks, according to a report by international rating agency S&P Global Ratings.

Shares of Noubar Afeyan’s Moderna soared 124% on news of a successful cancer vaccine trial

YEREVAN, August 20. /ARKA/. Shares of the biotech company Moderna soared 123.6% at the start of trading in the US on August 19, reaching a peak of $140.77, according to trading data. Shares of the pharmaceutical company Merck also rose 11.6% to $150.85, according to Forbes.ru.

LATEST NEWS

spot_imgspot_imgspot_img